Medical Triads Codexery

Triple-A syndrome

Rare autosomal recessive disorder with achalasia, addisonianism, and alacrima.

Triple-A syndrome

Triple-A syndrome, also known as AAA syndrome, is a rare autosomal recessive congenital disorder first identified by Jeremy Allgrove and colleagues in 1978. It is characterized by the triad of achalasia, addisonianism (primary adrenal insufficiency), and alacrima (absence of tear secretion), with alacrima usually being the earliest manifestation. The disorder is progressive and can take years to develop the full clinical picture, with variability and heterogeneity in presentation.

field
Medical genetics
known_for
Triple-A syndrome (achalasia, addisonianism, alacrima)
inheritance
Autosomal recessive
associated_gene
AAAS gene (encodes ALADIN protein)
chromosome_location
12q13

Lore & Background

Triple-A syndrome was first identified by Jeremy Allgrove and colleagues in 1978, and since then just over 100 cases have been reported. In most cases, there is no family history of the syndrome. The disorder is associated with mutations in the AAAS gene, which encodes the ALADIN protein, a component of the nuclear pore complex. Mutant ALADIN mis-localizes in the cytoplasm, causing selective failure of nuclear protein import and hypersensitivity to oxidative stress, as well as decreased nuclear import of DNA repair proteins such as aprataxin and DNA ligase I, potentially leading to cell death.

Reader's Guide

Triple-A syndrome is significant as a rare genetic disorder that illustrates the complex interplay between nuclear pore function, DNA repair, and multisystem disease. Its progressive nature and variable presentation—including neurodegeneration, autonomic dysfunction, and mild intellectual disability—highlight the challenges in diagnosis and management. The syndrome is typically managed symptomatically with hormone replacement for adrenal insufficiency, lubricating eye drops, and surgical intervention for achalasia. Early diagnosis, aided by genetic testing, can prevent morbidity and improve growth in children. The discovery of genotypic heterogeneity suggests that other genes and environmental factors may also contribute to the phenotype, underscoring the need for further research into the mechanisms of this disorder.

Did You Know?

More in Medical triads 1-24

Spotted an error? Know more?

This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record

Comments

Loading…
Open in the interactive codex →